Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmunology|May 12, 2005
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment responseLaura Leyva, Oscar Fernández, Maria Fedetz, et al.
Neurological Research|April 15, 2016
S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injuryAna Rodríguez-Rodríguez, Juan José Egea-Guerrero, Elena Gordillo-Escobar, et al.
Food Research International (Ottawa, Ont.)|November 17, 2019
Lupine protein hydrolysates decrease the inflammatory response and improve the oxidative status in human peripheral lymphocytesIvan Cruz-Chamorro, Nuria Álvarez-Sánchez, María Del Carmen Millán-Linares, et al.
Histology and Histopathology|September 29, 2012
Melatonin-synthesizing enzymes and melatonin receptor in rat thyroid cellsRocío García-Marín, Manuel de Miguel, José María Fernández-Santos, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 9, 2019
Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantationHada Celicia Macher, Noelia García-Fernández, Alejandro Adsuar-Gómez, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 4, 2012
Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adultsAna Rodríguez-Rodríguez, Juan José Egea-Guerrero, Antonio León-Justel, et al.
Nutrients|June 10, 2020
Immunomodulatory and Antioxidant Properties of Wheat Gluten Protein Hydrolysates in Human Peripheral Blood Mononuclear CellsIvan Cruz-Chamorro, Nuria Álvarez-Sánchez, Guillermo Santos-Sánchez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 monthsBegoña Oliver, Oscar Fernández, Teresa Orpez, et al.
Brain Injury|January 23, 2018
Validation of S100B use in a cohort of Spanish patients with mild traumatic brain injury: a multicentre studyJuan José Egea-Guerrero, Ana Rodríguez-Rodríguez, Manuel Quintana-Díaz, et al.
Journal of Medicinal Chemistry|February 2, 2019
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)Miguel Guerrero, Mariangela Urbano, Eun-Kyong Kim, et al.
Pageof 9